Literature DB >> 19515868

Natural killer cell counts are not different between patients with post-Lyme disease syndrome and controls.

Adriana Marques1, Margaret R Brown, Thomas A Fleisher.   

Abstract

It has been reported that patients with "chronic Lyme disease" have a decreased number of natural killer cells, as defined by the CD57 marker. We performed immunophenotyping in 9 individuals with post-Lyme disease syndrome, 12 who recovered from Lyme disease, and 9 healthy volunteers. The number of natural killer cells was not significantly different between the groups.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19515868      PMCID： PMC2725528          DOI： 10.1128/CVI.00167-09

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  10 in total

Review 1.  A critical appraisal of "chronic Lyme disease".

Authors:  Henry M Feder; Barbara J B Johnson; Susan O'Connell; Eugene D Shapiro; Allen C Steere; Gary P Wormser; W A Agger; H Artsob; P Auwaerter; J S Dumler; J S Bakken; L K Bockenstedt; J Green; R J Dattwyler; J Munoz; R B Nadelman; I Schwartz; T Draper; E McSweegan; J J Halperin; M S Klempner; P J Krause; P Mead; M Morshed; R Porwancher; J D Radolf; R P Smith; S Sood; A Weinstein; S J Wong; L Zemel
Journal:  N Engl J Med       Date:  2007-10-04       Impact factor: 91.245

2.  Case definitions for infectious conditions under public health surveillance. Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1997-05-02

3.  The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America.

Authors:  Gary P Wormser; Raymond J Dattwyler; Eugene D Shapiro; John J Halperin; Allen C Steere; Mark S Klempner; Peter J Krause; Johan S Bakken; Franc Strle; Gerold Stanek; Linda Bockenstedt; Durland Fish; J Stephen Dumler; Robert B Nadelman
Journal:  Clin Infect Dis       Date:  2006-10-02       Impact factor: 9.079

4.  Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1995-08-11       Impact factor: 17.586

5.  Decreased CD57 lymphocyte subset in patients with chronic Lyme disease.

Authors:  R B Stricker; E E Winger
Journal:  Immunol Lett       Date:  2001-02-01       Impact factor: 3.685

Review 6.  Lyme borreliosis in 2005, 30 years after initial observations in Lyme Connecticut.

Authors:  Allen C Steere
Journal:  Wien Klin Wochenschr       Date:  2006-11       Impact factor: 1.704

Review 7.  Chronic Lyme disease: a review.

Authors:  Adriana Marques
Journal:  Infect Dis Clin North Am       Date:  2008-06       Impact factor: 5.982

8.  Musical hallucinations in patients with Lyme disease.

Authors:  Raphael B Stricker; Edward E Winger
Journal:  South Med J       Date:  2003-07       Impact factor: 0.954

9.  Longterm decrease in the CD57 lymphocyte subset in a patient with chronic Lyme disease.

Authors:  Raphael B Stricker; Joseph Burrascano; Edward Winger
Journal:  Ann Agric Environ Med       Date:  2002       Impact factor: 1.447

10.  The cytolytic enzymes granyzme A, granzyme B, and perforin: expression patterns, cell distribution, and their relationship to cell maturity and bright CD57 expression.

Authors:  Pratip K Chattopadhyay; Michael R Betts; David A Price; Emma Gostick; Helen Horton; Mario Roederer; Stephen C De Rosa
Journal:  J Leukoc Biol       Date:  2008-10-10       Impact factor: 4.962
  10 in total
  13 in total

1.  Natural killer cells in chronic Lyme disease.

Authors:  Raphael B Stricker; Edward E Winger
Journal:  Clin Vaccine Immunol       Date:  2009-11

Review 2.  Laboratory diagnosis of Lyme disease: advances and challenges.

Authors:  Adriana R Marques
Journal:  Infect Dis Clin North Am       Date:  2015-06       Impact factor: 5.982

Review 3.  Chronic Lyme disease.

Authors:  Paul M Lantos
Journal:  Infect Dis Clin North Am       Date:  2015-06       Impact factor: 5.982

4.  Antiscience and ethical concerns associated with advocacy of Lyme disease.

Authors:  Paul G Auwaerter; Johan S Bakken; Raymond J Dattwyler; J Stephen Dumler; John J Halperin; Edward McSweegan; Robert B Nadelman; Susan O'Connell; Eugene D Shapiro; Sunil K Sood; Allen C Steere; Arthur Weinstein; Gary P Wormser
Journal:  Lancet Infect Dis       Date:  2011-09       Impact factor: 25.071

Review 5.  Persistent Symptoms After Treatment of Lyme Disease.

Authors:  Adriana Marques
Journal:  Infect Dis Clin North Am       Date:  2022-09       Impact factor: 5.905

6.  Role of NK-Like CD8+ T Cells during Asymptomatic Borrelia burgdorferi Infection.

Authors:  Breanna M Scorza; Kurayi G Mahachi; Arin D Cox; Angela J Toepp; Danielle Pessoa-Pereira; Phyllis Tyrrell; Jesse Buch; Jennifer A Foltz; Dean Lee; Christine A Petersen
Journal:  Infect Immun       Date:  2022-04-13       Impact factor: 3.609

Review 7.  Diagnosis, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: A Review.

Authors:  Edgar Sanchez; Edouard Vannier; Gary P Wormser; Linden T Hu
Journal:  JAMA       Date:  2016-04-26       Impact factor: 56.272

Review 8.  Lyme disease: a review.

Authors:  Adriana R Marques
Journal:  Curr Allergy Asthma Rep       Date:  2010-01       Impact factor: 4.919

Review 9.  Functional Significance of CD57 Expression on Human NK Cells and Relevance to Disease.

Authors:  Carolyn M Nielsen; Matthew J White; Martin R Goodier; Eleanor M Riley
Journal:  Front Immunol       Date:  2013-12-09       Impact factor: 7.561

10.  Natural killer cells and natural killer T cells in Lyme arthritis.

Authors:  Kia Katchar; Elise E Drouin; Allen C Steere
Journal:  Arthritis Res Ther       Date:  2013-11-07       Impact factor: 5.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.